F.P. Bymaster

A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.

David T. Wong, Penny G. Threlkeld, Kevin L. Best et al. · Journal of Pharmacology and Experimental Therapeutics · 1982 · 192 citations · Full text

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum

Ximing Li, Kenneth W. Perry, David T. Wong et al. · Psychopharmacology · 1998 · 191 citations

Neuropsychology, Olanzapine Increases, Psychotropic Medication +16

The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D 1 , D 2 , D 3 , 5HT 2A and muscarinic receptors

W. Zhang, F.P. Bymaster · Psychopharmacology · 1999 · 159 citations

Receptor Occupancy, Psychoactive Drug, Psychiatry +12

Olanzapine: a basic science update

F.P. Bymaster, Kenneth W. Perry, David L. Nelson et al. · The British Journal of Psychiatry · 1999 · 149 citations

Neuropsychology, Psychotropic Medication, Psychopharmacology +16

Duloxetine (Cymbalta™), a dual inhibitor of serotonin and norepinephrine reuptake

F.P. Bymaster, E. E. Beedle, Jeremy Findlay et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 121 citations · Full text

Molecular Pharmacology, Psychiatry, Medicine +11